Coherus Management to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

REDWOOD CITY, Calif., Sept. 10, 2021 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at the 23rd Annual H.C. Wainwright Global Investment Conference. The presentation will be made available at 7 a.m. ET on Tuesday, September 14, 2021, during the virtual conference.

The audio portion of the presentation will be available on the investors’ page of the Coherus Biosciences website at

About Coherus BioSciences
Coherus is a commercial stage biopharmaceutical company with the mission to increase access to cost-effective medicines that can have a major impact on patients’ lives and to deliver significant savings to the health care system. Coherus’ strategy is to build a leading immuno-oncology franchise funded with cash generated by its commercial biosimilar business. For additional information, please visit

Coherus Contact Information:
IR Contact:
McDavid Stilwell
Coherus BioSciences, Inc.
+1 (650) 395-0152

Media Contact:
Sheryl Seapy
Real Chemistry
+1 (949) 903-4750

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.